Jan 25, 2023 | News
SUGAR LAND, TX – (January 25, 2023) Outpatient parenteral antimicrobial therapy (OPAT) has been shown to be safe and effective for self-administration but can lead to non-adherence. OPAT provided through a physician office infusion center (POIC) with pharmacy...
Jul 1, 2022 | News
SUGAR LAND, TX – (July 1, 2022) Subcutaneous immune globulin (IGSC) is indicated for the treatment of primary immunodeficiences (PID) and offers the convenience of self-administration, fewer systemic reactions, and more stable IgG levels compared to intravenous IG...
Feb 16, 2022 | News
SUGAR LAND, TX – (February 16, 2022) The coronavirus disease 2019 (COVID-19) pandemic dramatically affected the provision of healthcare in the U.S. with sharp declines in routine and elective healthcare services. A study evaluated how COVID-19 impacted the provision...
Feb 16, 2022 | News
SUGAR LAND, TX – (February 16, 2022) Resistant Gram-negative pathogens (GNP) are a primary cause of many infections, particularly genitourinary tract infections (GUI). High recurrence rates and increasing antibiotic resistance often require intravenous antibiotics...
Apr 14, 2020 | News
SUGAR LAND, TX – (March 20, 2020) Healix Infusion Therapy, LLC, announced today the publication of a collaborative study in the leading scientific journal, Open Forum Infectious Diseases. This real-world multicenter study demonstrated successful prevention of...
Recent Comments